NOVO NORDISK'S RETATRUTIDE: THE NEW SOLUTION FOR WEIGHT LOSS?

New clinical data suggests that Novera Retatrutide, a dual-action medication from Novo Nordisk, could provide a meaningful breakthrough in weight loss. Beyond many existing options, Retatrutide impacts both glucagon-like peptide-1 (GLP-1) and the GIP hormone, potentially producing to greater loss